Study identifies the epigenetic basis of immunodeficiency disorder

Posted by administrator on June 18, 2015

CVID is a disorder characterized by low levels of antibodies (serum immunoglobulins) and increased susceptibility to infections. Most patients with CVID are diagnosed initially after suffering recurrent infections that involve ears, sinuses, nose, bronchi and lungs. When the lung infections are severe and occur repeatedly, can cause permanent damage to the bronchi and become chronically affected.

The exact cause of low levels of serum immunoglobulins is not known. Given the heterogeneous nature of CVID, there is not a clear pattern of inheritance, although in recent years geneticists have described mutations in several genes related to the biology of lymphocytes in patients with CVID. Still, for several patients there are no identified mutations and it is thought that other mechanisms also determine the onset of the disease; in fact, there are examples of genetically identical twins, which are discordant for the manifestation of this disease.

The current study was conducted in collaboration by researchers of the Chromatin and Disease Group at the Bellvitge Biomedical Research Institute (IDIBELL) and La Paz Hospital (IDIPAZ) in Spain, and the Computational Medicine team at Karolinska Institutet’sDepartment of Medicine, SolnaBy comparing the epigenetic marks in B cells of a pair of identical twins, discordant for CVID, the researchers were able to identify the existence of epigenetic alterations in the twin with the immunodeficiency that are not present in the healthy twin. In particular, they observed higher DNA methylation levels in the twin with CVID. DNA methylation is related to the ability of cells to allow their genes to be expressed.

A group of genes

According to the researchers, this analysis allowed the identification of a group of genes important for the proper functioning of B lymphocytes which were more methylated in the CVID twin. Subsequently, the same genes were investigated in a cohort of individuals with CVID, and compared with a series of healthy individuals.

The analysis of methylation of these genes in cells in different stages of maturation also showed that patients with CVID have partially lost the ability of demethylating those genes during the process of generating mature lymphocytes. These results indicate that patients not only produce less CVID memory B cells (the mature form which produces antibodies) but these cells are altered and have not completed properly their maturation.

This work was supported by the Spanish Ministry of Economy and Competitiveness, the Fundación Ramón Areces, and the EU FP7 306000 STATegra project. This news article is an abbrivation of a press release from the IDIBELL



Monozygotic Twins Discordant for Common Variable Immunodeficiency Reveal Impaired DNA Demethylation during Naïve-to-Memory B-Cell Transition
Virginia C. Rodríguez-Cortez, Lucia del Pino-Molina, Javier Rodríguez-Ubreva, Laura Ciudad, David Gómez-Cabrero, Carlos Company, José M. Urquiza, Jesper Tegnér, Carlos Rodríguez-Gallego, Eduardo López-Granados and Esteban Ballestar
Nature Communications, online 17 June 2015, DOI: 10.1038/ncomms8335

Source: Karolinska Institutet, KI News

Unit of Computational Medicine

Karolinska University Hospital, L8:05
SE-171 76 Stockholm

Phone: +46 8 517 708 69
Cell phone: + 46 72 530 75 53